首页> 外文OA文献 >P2-197: A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC)

【2h】

P2-197: A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC)

机译：P2-197：III期非小细胞肺癌（NSCLC）患者每周进行多西他赛/顺铂联合放射治疗及手术的II期研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Maas K.W.; Sharouni S.Y.; Phernambucq E.C.; Stigt J.A.; van den Borne B.E.; Groen H.J.; Senan S; Smit E.F.; Paul R.A.; Schramel F.M.;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 6602 POSTER Induction docetaxel and cisplatin followed by bi-weekly docetaxel with concurrent thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC). A phase II study conducted by the Galician Lung Cancer Group (GLCG) [J] . J.Casal Rubio, S.Vazquez Estevez, M.Lazaro Quintela, European Journal of Cancer Supplements . 2007,第4期

机译：6602 POSTER诱导多西紫杉醇和顺铂，然后每两周一次多西紫杉醇并发胸腔放疗，用于III期非小细胞肺癌（NSCLC）。加利西亚肺癌小组（GLCG）进行的II期研究
2. 9104 Randomized phase III study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (CTR) for patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC): West Japan Thoracic Oncology Group (WJTOG) 0105 [J] . N.Katakami, M.Satouchi, N.Yamamoto, European Journal of Cancer Supplements . 2009,第2期

机译：9104丝裂霉素/长春地辛/顺铂（MVP）与每周伊立替康/卡铂（IC）或每周紫杉醇/卡铂（PC）联合胸腔放疗（CTR）的不可切除的III期非小细胞患者的3期随机研究肺癌（NSCLC）：西日本胸腔肿瘤小组（WJTOG）0105
3. 9100 Induction Docetaxel (D) and Cisplatin (C) plus concurrent Thoracic Radiotherapy (TRT) and biweekly D and C for stage III non-small cell lung cancer (NSCLC) - a Galician Lung Cancer Group study [J] . J. CasalRubio, S.Vazquez Estevez, M. LázaroQuintela, European Journal of Cancer Supplements . 2009,第2期

机译：9100诱导多西紫杉醇（D）和顺铂（C）联合同期胸腔放疗（TRT）以及双周D和C治疗III期非小细胞肺癌（NSCLC）-加利西亚肺癌小组研究
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Evaluation of Symptom Management in Patients with Advanced Stage (IIIB and IV) Non-Small Cell Lung Cancer [D] . Mann, LaTonya E. 2018

机译：晚期（IIIB和IV）非小细胞肺癌患者症状管理的评估
6. Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer [O] . Qian Zhao, Zhongtang Wang, Wei Huang, 2016

机译：不可切除的Ⅲ期非小细胞肺癌患者顺铂联合培美曲塞或长春瑞滨联合晚期晚期加速超分割放疗的III期研究
7. P2-167: Induction docetaxel and cisplatin followed of bi-weekly docetaxel with concurrent thoracic radiotherapy for stage III non-small cell lung cancer (NSCLC). A phase II study conducted by the Galician Lung Cancer Group (GLCG). [O] . Casal Joaquin R., Vazquez Sergio E., Lázaro Martin Q., 2007

机译：P2-167：对多西他赛和顺铂进行诱导，每两周一次多西他赛，并发胸腔放疗，用于III期非小细胞肺癌（NSCLC）。加利西亚肺癌小组（GLCG）进行的II期研究。

P2-197: A phase II study of weekly docetaxel/cisplatin and concurrent radiotherapy followed by surgery in patients with stage III non-small cell lung cancer (NSCLC)

著录项

相似文献

相关主题

期刊订阅